FEL D 1 PLANT ENVELOPED BIOPARTICLES, A CANDIDATE CAT ALLERGY IMMUNOTHERAPY WITH EXCELLENT HYPOALLERGENIC PROPERTIES.

被引:0
|
作者
Wu, L.
Aglas, L.
Van Ree, R.
Tropper, G.
Gutierrez, B. Cifuentes
Shamji, M.
Colin, P.
Scadding, G.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
R054
引用
收藏
页码:S21 / S22
页数:2
相关论文
共 25 条
  • [1] Immunotherapy with recombinant Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy
    Saarne, T.
    Neimert-Andersson, T.
    Gronlund, H.
    Bigdeli, N.
    Gafvelin, G.
    van Hage, M.
    ALLERGY, 2009, 64 : 149 - 150
  • [2] Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction
    Curin, M.
    Weber, M.
    Thalhamer, T.
    Swoboda, I.
    Focke-Tejkl, M.
    Blatt, K.
    Valent, P.
    Marth, K.
    Garmatiuk, T.
    Gronlund, H.
    Thalhamer, J.
    Spitzauer, S.
    Valenta, R.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (06): : 882 - 894
  • [3] Covalent coupling of vitamin d3 to fel d 1 improves the effects of immunotherapy in a mouse model of cat allergy
    Grundstrom, J.
    Andersson, Neimert T.
    Nilsson, O.
    Saarne, T.
    Andersson, M.
    van Hage, M.
    Gafvelin, G.
    ALLERGY, 2010, 65 : 269 - 270
  • [4] Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy
    van Ree, R
    van Leeuwen, WA
    Bulder, I
    Bond, J
    Aalberse, RC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) : 1223 - 1230
  • [5] Design of hypoallergenic derivatives of the major cat allergen Fel d 1 by rational reassembly as a mosaic protein
    Curin, M.
    Swoboda, I.
    Focke, M.
    Blatt, K.
    Valent, P.
    Gronlund, H.
    Spitzauer, S.
    Valenta, R.
    IMMUNOLOGY, 2012, 137 : 443 - 443
  • [6] Fel d 1 expressing bioparticle: A novel therapeutic option for cat allergy
    Layhadi, J. A.
    Filipaviciute, P.
    Wu, L.
    Sarama, R.
    Meng, X.
    Fedina, O.
    Gil, A.
    Tropper, G.
    Gomord, V
    Stordeur, V
    Desgagnes, R.
    Vezina, L. P.
    Durham, S.
    van Ree, R.
    Shamji, M.
    ALLERGY, 2023, 78 : 22 - 22
  • [7] The effect of reducing levels of cat allergen (Fel d 1) on clinical symptoms in patients with cat allergy
    Björnsdottir, US
    Jakobinudottir, S
    Runarsdottir, V
    Juliusson, S
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) : 189 - 194
  • [8] A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
    Castenmiller, Charlotte
    Nagy, Noemi Anna
    Kroon, Pascal Zion
    Auger, Lydia
    Desgagnes, Rejean
    Martel, Caroline
    Mirande, Lucie
    Morel, Bertrand
    Roberge, Joannie
    Stordeur, Virginie
    Tropper, Guy
    Vezina, Louis Philipe
    van Ree, Ronald
    Gomord, Veronique
    de Jong, Esther Christina
    WORLD ALLERGY ORGANIZATION JOURNAL, 2023, 16 (11):
  • [9] A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS
    Niespodziana, Katarzyna
    Focke-Tejkl, Margarete
    Linhart, Birgit
    Civaj, Vera
    Blatt, Katharina
    Valent, Peter
    van Hage, Marianne
    Gronlund, Hans
    Valenta, Rudolf
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (06) : 1562 - U375
  • [10] Persistent treatment effect on ocular and nasal symptoms of cat allergy 1 year after four doses of Fel d 1 peptide immunotherapy
    Hafner, R.
    Efthimiou, J.
    Salapatek, A.
    Couroux, P.
    Patel, D.
    Larche, M.
    ALLERGY, 2012, 67 : 13 - 13